Further Clinical Study on Painful Menses and its Management By Enema of oil

Further Clinical Study on Kastartava wsr to Primary Dysmenorrhoea & its Management by Matra Basti

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/01/004272

Enrollment

Registered

2014-01-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primary Dysmenorrhoea-Kastartav

Interventions

Intervention1: MATRA BASTI OF DASHAMOOLA TAIL-60ml PER DAY FOR TWO CONSECUTIVE CYCLES ERANDA BRUSHTA HARITAKI WITH SHUNTI CHOORNA-12g TWICE A DAY FOR TWO CONSECUTIVE CYCLES: PATIENTS WILL BE RANDOMLY

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS COMING WITH CHIEF COMPLAINS OF PAINFUL MENSES AT LEAST THREE CYCLE. PAIN ALONG WITH SCANTY OR IRREGULAR MENSES. AGE GROUP BETWEEN 15-30 YEARS.

Exclusion criteria

Exclusion criteria: PATIENTS BELOW 15 YEARS AND ABOVE 30 YEARS. PATIENTS WITH CHRONIC ILLNESS. E.G. HYPERTENSION, DIABETIC MELLITUS PATIENTS WITH INTRAUTERINE CONTRACEPTIVE DEVICES. ANY UTERINE PATHOLOGY â?? FIBROID, ADENOMYOSIS TUBERCULOSIS ,ENDOMETRIOSIS ETC.

Design outcomes

Primary

Measure	Time frame
BETTERMENT IN VEDANA PAIN REGULARITY OF MENSTRUAL CYCLE Timepoint: AFTER 2 MONTHS OF TREATMENT	—

Secondary

Measure	Time frame
BETTERMENT IN VEDANA PAIN REGULARITY OF MENSTRUAL CYCLE BETTERMENT IN ENDOMETRIAL THICKNESS AND ENDOMETRIAL FLOW PI AND RI VALUE ACCORDING TO SONOGRAPHYTimepoint: 2 MONTHS	—

Countries

India

Contacts

Public ContactDRLPDEI

IPGT & RA GUJARAT AYURVED UNIVERSITY

dr.shahan@gmail.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026